Lyngbæk et al. found that suPAR and CRP were significantly increased in participants who experienced a cardiovascular disease event compared to those who experienced no event (suPAR; 3.93 ng/mL (95% confidence intervals= 2.61-6.48) vs. 4.53 ng/mL (2.86-7.86), CRP; 1.61 mg/L (0.31-11.1) vs. 2.63 mg/L (0.40-13.8), respectively, p<0.0001). This evidence concerns the gene CRP and cardiovascular disorder.